ASCO 2022 Conference Coverage


 

ASCO 2022 on Olaparib + Abiraterone as 1L Therapy for mCRPC: Pharmacokinetics Data From the PROpel Trial

264 views
July 9, 2022
Comments 0
Login to view comments. Click here to Login